---
figid: PMC6214138__ijms-19-03198-g002
figtitle: Canonical FLT3 and mutant FLT3 signaling pathways
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC6214138
filename: ijms-19-03198-g002.jpg
figlink: /pmc/articles/PMC6214138/figure/ijms-19-03198-f002/
number: F2
caption: Canonical FLT3 and mutant FLT3 signaling pathways. Similar and divergent
  signaling pathways of wild-type and mutant FLT3 identified by functional genomic
  studies and large scale proteomic profiling experiments. (A) Upon binding of the
  FLT3 ligand (FLT3L), the FLT3 receptor undergoes a change in conformation and trans-autophosphorylation.
  (B) FLT3-ITD, (C) FLT3-TKD and (D) FLT3-ITD-TKD dual mutations lead to constitutive,
  ligand independent activation of the FLT3 receptor. Subsequent recruitment of adaptor
  proteins effects the activation of downstream kinase signaling pathways, such as
  MAPK, JAK-STAT, and PI3K. Coloring indicates activation of pathway phosphorylation
  or expression changes associated with the wild-type and mutant FLT3 receptor forms.
  Numbers indicate amino acid residues of the human protein sequence. Figure created
  using data from references [,,,,,,,,,,,,,].
papertitle: 'Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia:
  The Path to Least Resistance.'
reftext: Dilana Staudt, et al. Int J Mol Sci. 2018 Oct;19(10):3198.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.94244
figid_alias: PMC6214138__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC6214138__F2
ndex: d88db588-def9-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6214138__ijms-19-03198-g002.html
  '@type': Dataset
  description: Canonical FLT3 and mutant FLT3 signaling pathways. Similar and divergent
    signaling pathways of wild-type and mutant FLT3 identified by functional genomic
    studies and large scale proteomic profiling experiments. (A) Upon binding of the
    FLT3 ligand (FLT3L), the FLT3 receptor undergoes a change in conformation and
    trans-autophosphorylation. (B) FLT3-ITD, (C) FLT3-TKD and (D) FLT3-ITD-TKD dual
    mutations lead to constitutive, ligand independent activation of the FLT3 receptor.
    Subsequent recruitment of adaptor proteins effects the activation of downstream
    kinase signaling pathways, such as MAPK, JAK-STAT, and PI3K. Coloring indicates
    activation of pathway phosphorylation or expression changes associated with the
    wild-type and mutant FLT3 receptor forms. Numbers indicate amino acid residues
    of the human protein sequence. Figure created using data from references [,,,,,,,,,,,,,].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Flt3
  - Akt1
  - Pt
  - Pclo
  - Pgr
  - S100a6
  - Ptpra
  - She
  - Sta
  - Emd
  - Caf
  - Zhx2
  - Mtor
  - Bad
  - Rrad
  - Garin1a
  - Ptpa
  - Sorbs1
  - Lnpep
  - Pik3ap1
  - Lyn
  - Zdhhc21
  - tor
  - Rorc
  - Ptcra
  - F11
  - Prot
  - Slc6a7
  - Timp1
  - Ty
  - Get4
  - FLT3
  - AKT1
  - AKT2
  - AKT3
  - S100A6
  - PTPRA
  - SHE
  - EMD
  - GCY
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - KAT2B
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AP2B1
  - AP2M1
  - AP2S1
  - AP3B1
  - AP3D1
  - AP3S1
  - AP3S2
  - AP1B1
  - AP1G1
  - AP1M1
  - AP1M2
  - AP1S1
  - AP1S2
  - AP1S3
  - AP4B1
  - AP4E1
  - AP4M1
  - AP4S1
  - AP5Z1
  - AP5B1
  - AP5M1
  - AP5S1
  - AP2A1
  - AP2A2
  - MTOR
  - BAD
  - RRAD
  - GARIN1A
  - A1BG
  - PTPA
  - CTAA1
  - LNPEP
  - SERPINB6
  - HACD1
  - CAP1
  - SORBS1
  - BRD4
  - CAP2
  - PHF11
  - PIK3AP1
  - LYN
  - RORC
  - CD200
  - MRC1
  - MRC2
  - POMC
  - PTCRA
  - SLC6A7
  - TIMP1
  - PRAC1
  - GET4
  - RAD
---
